To the best of our knowledge, the present study was the first to investigate the therapeutic effect of SGD in a TNBS-induced PI-IBS rat model and to examine whether the therapeutic effect of visceral hypersensitivity may be mediated by 5-HT and TRPV1 signaling. The gene discussed is TRPV1; the disease is irritable bowel syndrome.